טוען...
Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity
AIMS: Myocarditis is often associated with parvovirus B19 (B19V) persistence, which can induce vascular damage. Based on the antiviral and anti‐inflammatory properties of telbivudine, we aimed to evaluate its efficacy to protect B19V‐infected endothelial cells in vitro and to treat chronic lymphocyt...
שמור ב:
| הוצא לאור ב: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6165949/ https://ncbi.nlm.nih.gov/pubmed/30099854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12341 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|